NCT06929728

Brief Summary

comparing automatic blood pressure measurments methods with conventional office methods in follow up and monitoring of hypertensive patients and predicting hypertension mediated organ damage .

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
620

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Oct 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Oct 2025Dec 2026

First Submitted

Initial submission to the registry

March 25, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

April 16, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

April 16, 2025

Status Verified

April 1, 2025

Enrollment Period

1 year

First QC Date

March 25, 2025

Last Update Submit

April 8, 2025

Conditions

Keywords

HTN , HMOD ,BP , LVH ,LAE

Outcome Measures

Primary Outcomes (1)

  • predictive accuracy of automatic blood pressure measurments versus conventional office based measurments in identifying patient at risk of hypertension mediated organ damage [HMOD] .

    this outcomes will be assessed by measuring systolic and diastolic blood pressure using both automated devices \[eg omron HEM -907\] and conventional manual sphygmomanometers in a seated postion ,after 5 minutes of rest .measurments will be taken in duplicate on two separate visits ,one week apart and the average readings will be used for analysis .the presence of HMOD will be evaluated through echocardiographic assessment of left ventricular hypertrophy \[LVH \] and microalbuminuria .correlation and predictive value \[ sensitivity , specificity\] will be calculated to compare both methods

    over 6 months follow up period

Study Arms (2)

Group 1

this group use office conventional methods of blood pressure measurments 3 separate readings at different visits

Device: blood pressure measurments devices

group 2

divided into 2 groups 1. st group used home methods twice daily in morning and in evening using cuff digital machine 2. nd group use unattended automatic office blood pressure measurments in 3 readings

Device: blood pressure measurments devices

Interventions

measure arterial blood pressure by arm cuff devises

Group 1group 2

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A calculated minimum sample of 620 male and female hypertensive patients aged more than 18 years old recruited from outpatient clinic of assiut cardiology departement will be randomly assigned 1:1 design.

You may qualify if:

  • Patients who were screening for suspected hypertention or white coat hypertention .
  • medically underserved population .
  • primary arterial hypertention .
  • high risk hypertensive patients \[resistant hypertension ,patients with poor medication adherance \]

You may not qualify if:

  • patients with secondary causes of hypertention
  • patients with other cardiac diseases \[heart faliure ,valvular heart diseases \]
  • chronic illness affect blood pressure as chronic kideny disease .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Essential HypertensionHypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Central Study Contacts

vereena karam william, resident doctor

CONTACT

Noha mouhamed gamal, assistant lecture

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Doctor

Study Record Dates

First Submitted

March 25, 2025

First Posted

April 16, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

April 16, 2025

Record last verified: 2025-04